Your browser doesn't support javascript.
loading
CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes.
Ostrominski, John W; Yada, Ravi Chandra; Sato, Noriko; Klein, Michael; Blinova, Ksenia; Patel, Dakshesh; Valadez, Racquel; Palisoc, Maryknoll; Pittaluga, Stefania; Peng, Kah-Whye; San, Hong; Lin, Yongshun; Basuli, Falguni; Zhang, Xiang; Swenson, Rolf E; Haigney, Mark; Choyke, Peter L; Zou, Jizhong; Boehm, Manfred; Hong, So Gun; Dunbar, Cynthia E.
Afiliação
  • Ostrominski JW; Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Yada RC; Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Sato N; Molecular Imaging Program, Laboratory of Cellular Therapeutics, National Cancer Institute (NCI), NIH, Bethesda, Maryland, USA.
  • Klein M; Division of Cardiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Blinova K; Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Patel D; Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Valadez R; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Palisoc M; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Pittaluga S; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Peng KW; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • San H; Animal Surgery and Resources Core, NHLBI, NIH, Bethesda, Maryland, USA.
  • Lin Y; iPSC Core, NHLBI, NIH, Bethesda, Maryland, USA.
  • Basuli F; Chemistry and Synthesis Center, NHLBI, NIH, Bethesda, Maryland, USA.
  • Zhang X; Chemistry and Synthesis Center, NHLBI, NIH, Bethesda, Maryland, USA.
  • Swenson RE; Chemistry and Synthesis Center, NHLBI, NIH, Bethesda, Maryland, USA.
  • Haigney M; Division of Cardiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Choyke PL; Molecular Imaging Program, Laboratory of Cellular Therapeutics, National Cancer Institute (NCI), NIH, Bethesda, Maryland, USA.
  • Zou J; iPSC Core, NHLBI, NIH, Bethesda, Maryland, USA.
  • Boehm M; Laboratory of Cardiovascular Regenerative Medicine, NHLBI, NIH, Bethesda, Maryland, USA.
  • Hong SG; Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Dunbar CE; Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Stem Cells Transl Med ; 9(10): 1203-1217, 2020 10.
Article em En | MEDLINE | ID: mdl-32700830
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simportadores / Miócitos Cardíacos / Células-Tronco Pluripotentes Induzidas / Sistemas CRISPR-Cas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simportadores / Miócitos Cardíacos / Células-Tronco Pluripotentes Induzidas / Sistemas CRISPR-Cas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article